Stocktoria

INNOSPEC INC. IOSP

Nasdaq · stock · Chemicals & Allied Products · website · IPO 1998-05-13 · LEI

INNOSPEC INC. (IOSP) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 2.08% (safety: n/a).

Chart by TradingView
57/100
Stocktoria Quality Score · grade C
3/9
Piotroski F — financial health
7.54
Altman Z″ — distress risk · safe
1.4%
Dividend yield 5y avg · n/a

Quality score trend · recomputed for each fiscal year

Piotroski F /9
4 3 4 4 3 3 3 3 2 3 2016201720182019202020212022202320242025
Altman Z″
4.84 4.74 5.06 5.92 6.51 6.74 7.29 7.54 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$93.12 as of 2026-08-01 · +6.3% 1y
$73.02$93.1252-wk
Market cap USD$2.0B
Dividend yield 5y avg1.4%
Beta0.91
Employees2,450

Analyst price target

$99.33 +6.7% vs last
consensus: strong buy · 3 analysts
target range $93.00 – $105.00

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Smart money · insiders, last 12 months

Insiders net sold -$405,504 on the open market · 6 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 10y · up

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 27%
Revenue growthstronger than 24%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 3/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.352
Retained earnings / assets0.6
EBIT / assets0.071
Equity / liabilities2.668

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
IOSPINNOSPEC INC.3/97.54-3.7%
NGVTIngevity Corp6/92.97-2.7%
BCPCBALCHEM CORP8/96.8235.5+8.8%
FMCFMC CORP2/91.38-18.3%
ACNTASCENT INDUSTRIES CO.6/98.71144.9-7.2%
BLGOBIOLARGO, INC.-56.3%
GUREGULF RESOURCES, INC.3/9-74.5%

All Manufacturing companies →

About INNOSPEC INC.

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company operates through three segments: Performance Chemicals, Fuel Specialties, and Oilfield Services. It offers specialty chemical products used as additives in diesel, jet, marine, fuel oil, and other fuels used in the operation of commercial trucking, marine and aviation engines, power station generators, heating oil, and other industrial machinery applications. It also provides technology-based solutions for customers' processes or products in personal care, home care, agrochemical, construction, mining, and other industrial markets. In addition, the company develops and markets chemical solutions for drilling, completion, production, drag reducing agents, and oil and gas applications. It serves large multinational companies, manufacturers of personal and home care products and global mining, agriculture and building products, and other industrial companies; national and multinational oil companies, fuel marketers and retailers, fuel terminals, marine lines, coating and plastics producers, and other heavy industrial end-users; and multinational public, independent exploration and production, and oilfield services companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.

FAQ

Is IOSP financially healthy?

INNOSPEC INC.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does IOSP pay a dividend, and is it safe?

Yes. INNOSPEC INC. pays a dividend yielding about 2.08% with a None payout ratio, rated “n/a” for safety.

Is IOSP overvalued or undervalued?

INNOSPEC INC. trades at about 19.9× trailing earnings — below its 10-year norm (10-year range 17.5×–79.8×, median 22.2×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for IOSP?

The average Wall-Street price target for INNOSPEC INC. is $99.33, about 6.7% above the recent price, from 3 analysts (consensus: strong buy).

Is IOSP a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on INNOSPEC INC.: a Piotroski F-score of 3/9, an Altman Z″ in the safe zone, a dividend yield of 2.08%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.